PCM
EFTRW

Prelude Capital Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Prelude Capital Management’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,055
Closed -$12K – 1799
2021
Q2 		$12K Buy
+12,055
New +$12K ﹤0.01% 1296